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ABSTRACT 
Previous studies have reported inconsistent associations between maternal serum ferritin 
concentrations and risk of preterm birth. The aim of this study was to examine the association 
between iron biomarkers, including serum ferritin and risk of total, early and moderate-to-late 
spontaneous preterm birth (sPTB). This cohort study included women with singleton 
pregnancies who were attending first-trimester screening in New South Wales, Australia.  
sPTB births included births <37 weeks gestation following spontaneous labour or preterm 
premature rupture of the membranes (PPROM). Sera were analysed for iron: serum ferritin 
and sTfR; and inflammatory: C-reactive protein (CRP) biomarkers. Multivariate logistic 
regression evaluated the association between low and high iron levels and sPTB. Women 
with elevated serum ferritin concentrations were more likely to be older, nulliparous or have 
gestational diabetes. Multivariate analyses found increased odds of sPTB for women with 
elevated ferritin levels defined as >75th percentile (≥43 µg/L) (OR: 1.49, 95% CI: 1.06, 2.10) 
and >90
th
 percentile (≥68 µg/L) (OR: 1.92, 95% CI: 1.25, 2.96).  Increased odds of early and 
moderate-to late sPTB were associated with ferritin levels >90
th
 (OR: 2.50, 95% CI: 1.32, 
4.73) and >75
th
 (OR: 1.56, 95% CI: 1.03, 2.37) percentiles, respectively.  No association was 
found between sPTB, and elevated sTfR levels or iron deficiency. In conclusion, elevated 
early pregnancy maternal serum ferritin levels are associated with increased risk of sPTB 
from 34 weeks gestation. The usefulness of early pregnancy ferritin levels in identifying 
women at risk of sPTB warrants further investigation. 
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BACKGROUND 
Preterm births continue to be the main cause of perinatal morbidity and mortality in 
developed countries, which increases the risk of neurocognitive and pulmonary deficits in 
surviving infants.
(1)
 Spontaneous preterm birth (sPTB) of unknown aetiology accounts for 40-
50% of all preterm deliveries,
(1)
 with the remainder attributable to maternal or fetal 
indications in which labour is induced or the infant is delivered by pre-labour caesarean 
section.
(2)
   
 
The aetiology of sPTB remains elusive.
(2)
 There is a body of evidence which suggests that 
infection in pregnancy may be related to preterm birth;
(3)
 however, the majority of 
randomised trials have not shown a significant reduction in preterm births following maternal 
administration of antibiotics.
(4)
 Early pregnancy factors associated with sPTB remain an 
important area of inquiry for identifying at-risk women to study specific interventions and 
treatments.   
 
The relationship between maternal iron status and risk of preterm delivery is uncertain.
(5)
 
Both low and elevated maternal iron has been associated with risk of preterm birth.
(6)
  While 
some randomised trials of iron supplementation in pregnancy report a reduction in preterm 
births,
(7)
 the most recent Cochrane
(8)
and systematic reviews
(9)
 of intervention trials found no 
significant effect of iron supplementation in pregnancy on risk of preterm birth.  In contrast, 
there are several observational studies which have found an association between elevated 
serum ferritin (a biomarker of iron stores) in the second trimester an increased risk of sPTB.
(1; 
10; 11; 12; 13; 14; 15)
 Potential mechanisms resulting in elevated ferritin being linked to sPTB 
include: intrauterine infection; failure of the maternal plasma volume to expand; and infection 
and inflammation.
(16)
 Ferritin production is increased with infection and inflammation as part 
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of the acute phase response; therefore, interpretation of these studies is challenging.  Results 
are conflicting with studies differing in their definition of sPTB and in the cut-off used for 
high ferritin (>50
th
, >75
th
, >90
th
 centiles).
(1; 10; 11; 12; 13; 14; 15)
 The majority of these studies do 
not adjust for confounding, such as age and parity and lacked information on inflammatory or 
iron biomarkers other than serum ferritin.  Therefore the aim of the current study was to 
examine the association between iron biomarkers, including serum ferritin and risk of total, 
early and moderate-to-late spontaneous preterm birth (sPTB).  
 
SUBJECTS AND METHODS  
Design and study population 
The study population included women with a singleton infant with a birth weight of at least 
400 grams or at least 20 weeks gestation and who attended first trimester Down syndrome 
screening between January and October 2007 and had results analysed by Pathology North, a 
state-wide public screening service in New South Wales, Australia. Serum samples that were 
archived and stored at -80 ºC were thawed and used for subsequent biochemical analysis.  
 
 
Biochemical analysis  
Serum samples for this study were thawed and analysed for serum ferritin (µg/L), soluble 
transferrin receptor (sTfR; nmol/L) and C-reactive protein (CRP; mg/L) using commercial 
assays. Serum ferritin was measured using a solid phase direct sandwich ELISA method 
(Calbiotech, Inc, CA, USA) with an interassay CV of 6.2%. sTfR was measured using an 
enzyme-linked immunosorbent assay (Quantikine IVD, Human TfR Immunoassay, R & D 
Systems, Minneapolis, MN, USA) with an interassay coefficient of variation (CV) of 6.4%.  
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CRP was measured using the quantitative sandwich enzyme immunoassay technique 
(QUANTIKINE™, Minneapolis, USA) with an interassay CV of 13.3%. 
Data sources 
Laboratory records and the results of each woman’s iron biomarker analyses were linked to 
electronic birth and hospital records sourced from the NSW Perinatal Data Collection (PDC) 
and the New South Wales Admitted Patients Data Collection (APDC), respectively to obtain 
pregnancy and birth information. The PDC is a statutory population-based collection of all 
births in NSW of at least 400 grams birth weight or at least 20 weeks of gestation, and 
includes information on maternal and infant characteristics, pregnancy, labour, delivery and 
infant characteristics at birth. The APDC is a census of all admissions in NSW public and 
private hospitals. Up to 50 diagnoses for each separation are coded according to the 10
th
 
revision of the International Classification of Diseases, Australian Modification (ICD-10-
AM).
(17)
  Validation studies of the PDC and the APDC show excellent level of agreement 
with the hospital medical record and low rates of missing data.
(18; 19)
 Reporting in both 
datasets have high specificity (>99%) indicating few false positive reports. Only variables 
known to be reliably reported in birth and/or hospital data were included in the analysis. The 
NSW Centre for Health Record Linkage (CHeReL) performed probabilistic record linkage 
between the three datasets.
(20)
 The CHeReL assesses the linkage quality for each study and 
for this study reported <5/1000 missed links and <2/1000 false positive links. Only de-
identified data were provided to the researchers. The study was approved by the NSW 
Population and Health Services Research Ethics Committee (HREC/09/CIPHS/52). 
 
Variables and definitions 
The primary outcome was spontaneous preterm birth (sPTB) defined as births <37 weeks 
gestation after the onset of spontaneous labour or preterm premature rupture of membranes 
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(PPROM) and subdivided into early (<34 weeks) and moderate-to-late (34-36) preterm 
births.
(2)
  Data on serum ferritin concentrations was examined continuously and as quartiles. 
Low ferritin was defined using the established definition for iron deficiency (serum ferritin 
<12 µg/L).
(21)
 There is no standard cut-off for high ferritin, therefore commonly used cut-offs 
in the literature were assigned at the 50
th
, 75
th
 and 90
th
 percentiles.
(1; 10; 11; 12; 13; 14; 15)
 As sTfR 
is an intercellular iron carrier protein, concentrations are inversely related to intracellular 
body iron concentrations. Data on TfR was examined continuously and also as iron deficient 
(TfR ≥21.0 nmol/L), according to manufacturer’s guidelines(22) and as high iron. Again 
similar to ferritin, there are not standard cut-offs for high TfR, therefore cut-offs which 
corresponded to those used for ferritin were used for TfR (<50
th
, <25
th
 and <10
th
 percentiles).   
 
Explanatory variables in the analysis included: maternal age, parity, gestational age at time of 
blood test, maternal body weight, country of birth, smoking during pregnancy, 
socioeconomic status, gestational diabetes, and hypertensive disorders in pregnancy.   
Electronic records from the laboratory database provided information on maternal body 
weight and gestational age at the time of screening.  Postcode was used to derive an indicator 
of socioeconomic status (SES). An Index of Relative Disadvantage produced by the 
Australian Bureau of Statistics and categorized into quintiles.
(23)
 Hospital data was used to 
identify PPROM and gestational diabetes mellitus (GDM) based on diagnosis by the 
attending clinician.
(19; 24; 25)
 Hypertensive disorders in pregnancy included women with the 
onset of hypertension from 20 weeks including gestational hypertension, preeclampsia and 
eclampsia.
(26)
 Missing data were infrequent with the following missing records excluded from 
analyses: maternal age (n= 16 records, 0.80%), smoking status (n= 11, 0.55%), country of 
birth (n= 29, 1.5%), and socioeconomic disadvantage (n= 12, 0.60%). 
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Statistical analysis  
Maternal, pregnancy characteristics and other iron and inflammatory biomarkers were 
examined by serum ferritin quartiles and differences were assessed using the Chi-squared 
(X
2
) test for categorical variables and the Kruskal-Wallis Test for continuous variables. When 
examined continuously, serum ferritin and CRP concentrations were log-transformed.   
Multivariate logistic regression analysis was performed to take into account any potential 
confounding with explanatory variables included in the full model. Separate models were 
performed examining serum ferritin as a continuous variable, as quartiles, as low ferritin (<12 
µg/L) and as high ferritin using three cutoffs: >50
th
, >75
th
 and >90
th
 percentiles.  These cut-
offs for elevated serum ferritin were examined to allow comparison with the cut-offs used in 
previous studies.
(1; 10; 11; 12; 13; 14; 15)
  Separate models were also performed examining the 
association between sPTB with sTfR treated as continuous variable and dichotomous 
variables for low and high sTfR.  
 
Final models were determined using backward stepwise selection, with variables of least 
significance progressively dropped from each model until all remaining covariates were 
statistically significant (2-tailed P<0.05). Variables not selected were then added back into 
the selected model, one at a time to assess whether they were confounders (i.e., changed the 
effect by more than 10%) and final model determined.  Statistical analysis was performed 
using SAS for Windows version 9.3 (SAS Institute Inc, Carey, North Carolina).    
 
RESULTS 
A total of 2,254 women with spontaneous labour or PPROM were included in the analysis. 
The median (25
th
, 75
th
) serum ferritin concentration for the total study population was 25.4 
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µg/L (14.5, 42.8).  The association between quartiles of serum ferritin concentrations and 
maternal and pregnancy characteristics are shown in Table 1.  
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Table 1 
Maternal serum ferritin quartiles by maternal and pregnancy characteristics and biochemical indices in women who had a spontaneous onset of 
labour or preterm premature rupture of the membranes (PPROM).   
 
 Serum ferritin quartiles  
 
 
P value*  
<15 µg/L 15-24 µg/L 25-42 µg/L ≥43 µg/L 
n=580 n=536 n=578 n=560 
N (%) N (%) N (%) N (%) 
Maternal characteristics      
Maternal age, years  
<25 
25-34 
≥35 
 
78 (13.6) 
342 (59.5) 
155 (27.0)  
 
49 (9.2) 
344 (64.5) 
140 (26.3) 
 
41 (7.2) 
391 (68.5) 
139 (24.3) 
 
27 (4.9) 
353 (63.8) 
173 (31.3) 
 
<0.0001 
Country of birth 
Australia  
New Zealand, North and South Americas 
Europe  
Middle East and Africa 
South and Southeast Asia  
Northeast Asia 
Other  
 
373 (64.3) 
18 (3.10) 
46 (7.9) 
26 (4.5) 
56 (9.7) 
41 (7.1) 
20 (3.5) 
 
343 (64.0) 
15 (2.8) 
30 (5.6) 
32 (6.0) 
58 (10.8) 
41 (7.7) 
17 (3.2) 
 
362 (62.6) 
19 (3.3) 
43 (7.4) 
19 (3.3) 
59 (10.2) 
54 (9.3) 
22 (3.8) 
 
344 (61.4) 
17 (3.0) 
38 (6.8) 
29 (5.2) 
61 (10.9) 
47 (8.4) 
24 (4.3) 
 
0.88 
Maternal weight quintiles (kg)
1
 
<55 
55-59 
60-65 
66-73 
≥74 
 
87 (17.7) 
106 (21.5) 
102 (20.7) 
97 (19.7) 
101 (20.5) 
 
93 (19.7) 
75 (15.9) 
127 (26.9) 
88 (18.6) 
90 (19.0) 
 
89 (18.0) 
88 (17.8) 
116 (23.4) 
112 (22.6) 
90 (18.2) 
 
100 (20.1) 
85 (17.1) 
96 (19.3) 
93 (18.7) 
123 (24.8) 
 
0.04 
Smoking during pregnancy 39 (6.8) 31 (5.8) 44 (7.7) 35 (6.3) 0.64 
Socioeconomic disadvantage quintiles 
1 (most disadvantage) 
2 
3 
 
119 (20.5) 
115 (19.8) 
133 (22.9) 
 
113 (21.2) 
84 (15.7) 
126 (23.6) 
 
110 (19.3) 
99 (17.4) 
116 (20.4) 
 
130 (23.3) 
91 (16.3) 
107 (19.2) 
 
0.32 
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4 
5 (least disadvantage) 
102 (17.6) 
111 (19.1) 
111 (20.8) 
100 (18.7) 
115 (20.2) 
130 (22.8) 
116 (20.8) 
114 (20.4) 
Pregnancy characteristics      
Nulliparous 268 (46.2) 292 (54.5) 315 (54.5) 340 (60.7) <0.0001 
Gestational age at blood sampling, weeks 
9-10 
11 
12-14 
 
41 (12.1) 
115 (34.0) 
182 (53.9) 
 
36 (11.0) 
125 (38.2) 
166 (50.8) 
 
52 (14.2) 
139 (37.9) 
176 (48.0) 
 
64 (16.1) 
145 (36.4) 
189 (47.5) 
 
0.33 
Gestational diabetes  2 (0.3) 17 (3.2) 18 (3.1) 17 (3.0) 0.003 
Hypertensive disorders in pregnancy 23 (4.0) 24 (4.5) 17 (2.9) 25 (4.5) 0.51 
Biochemical indices      
soluble transferrin receptor (sTfR), nmol/L  
Median (25
th
, 75
th 
percentiles) 
 
15.6 (12.2, 19.5) 
 
14.5 (11.6, 18.3) 
 
15.0 (12.0, 18.0) 
 
15.3 (12.5, 18.4) 
 
0.01 
C-reactive protein (CRP), mg/L 
Median (25
th
, 75
th 
percentiles) 
 
0.7 (0.3, 1.4) 
 
0.7 (0.3, 1.4) 
 
0.8 (0.3, 1.6) 
 
0.8 (0.3,1.8) 
 
0.13 
* P values were determined by using the Kruskal-Wallis Test. 
1 
Maternal body weight is collected by the healthcare professional referring women for Down Syndrome screening.
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Serum ferritin concentrations increased with increasing maternal age and body weight.  
Nulliparity and GDM were associated with higher serum ferritin concentrations (Table 1). 
Compared to women with term births, women with a sPTB <37 weeks were more likely to be 
heavier (P=0.05) and have GDM (P=0.007) (Table 2).  These women also had significantly 
higher median ferritin (25.3 vs. 26.5 µg/L, P=0.05) and CRP (0.7 vs. 1.0 mg/L, P=0.01) 
concentrations.  There was no difference in sTfR concentrations among women with a sPTB 
versus term birth (P=0.61).   
 
Univariate analysis found significant associations between elevated serum ferritin (defined 
>75
th
 and >90
th
 percentiles) and sPTB, but not sTfR concentrations (Table 3). No 
associations were found between low iron levels using either serum ferritin or sTfR. 
Multivariate analyses indicated increased odds of sPTB for serum ferritin concentrations 
>75
th
 percentile (≥43 µg/L) and >90th percentile (≥68 µg/L) of 1.49 (95% CI: 1.06, 2.10) and 
1.92 (95% CI: 1.25, 2.96), respectively (Table 3).  
 
Univariate analyses examining the association between low and elevated serum ferritin and 
sTfR concentrations stratified by early and moderate-to-late sPTB are presented in 
Supplementary Table 1. For early sPTB, women with serum ferritin concentrations >90
th
 
percentile had a 2.54 increased odds of early sPTB (95% CI: 1.36, 4.76) and this association 
remained significant in the fully adjusted analyses (OR: 2.50, 95% CI: 1.32, 4.73).  
 
Univariate analyses indicated increased odds for moderate-to-late sPTB for serum ferritin 
concentrations >75
th
 and >90
th
 percentiles (Supplementary Table 1).  Multivariate analyses 
found women with serum ferritin concentrations>75
th
 percentile had increased odds of 
moderate-to-late sPTB of 1.56 (95% CI: 1.03, 2.37).  
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Table 2 
Maternal characteristics, pregnancy characteristics and biochemical indices in women who 
had a spontaneous onset of labour or preterm premature rupture of the membranes (PPROM) 
and delivered a preterm or term infant.    
 
 Preterm birth 
 (<37 weeks)  
N=175 
Term birth 
(≥37 weeks)  
N=2, 079 
 
 
 
P-value*  N (%) N (%) 
Maternal age, years  
<25 
25-34 
≥35 
 
16 (9.3) 
118 (68.2) 
39 (22.5) 
 
179 (8.7) 
1312 (63.7) 
568 (27.6) 
 
0.36 
Nulliparous 105 (60.0) 1110 (53.4) 0.09 
Country of birth 
Australia  
New Zealand, North and South Americas 
Europe  
Middle East and Africa 
South and Southeast Asia  
Northeast Asia 
Other  
 
111 (63.4) 
6 (3.4) 
15 (8.6) 
11 (6.3) 
16 (9.1) 
9 (5.1) 
7 (4.0) 
 
1311 (63.1) 
63 (3.0) 
142 (6.8) 
95 (4.6) 
218 (10.5) 
174 (8.4) 
76 (3.7) 
 
0.65 
Gestational age at blood sampling, weeks 
9-10 
11 
12-14 
 
19 (15.3) 
42 (33.9) 
63 (50.8) 
 
174 (13.3) 
482 (36.9) 
650 (49.8) 
 
0.72 
Maternal body weight quintiles (kg) 
<55 
55-59 
60-65 
66-73 
≥74 
 
27 (17.9) 
20 (13.3) 
38 (25.2) 
23 (15.2) 
43 (28.5) 
 
342 (18.9) 
334 (18.5) 
403 (22.3) 
367 (20.3) 
361 (20.0) 
 
0.05 
Smoking during pregnancy 14 (8.0) 135 (6.5) 0.27 
Socioeconomic disadvantage quintiles 
1 (most disadvantage) 
2 
3 
4 
5 (least disadvantage) 
 
35 (20.0) 
30 (17.1) 
40 (22.9) 
32 (18.3) 
38 (21.7) 
 
437 (21.1) 
359 (17.4) 
442 (21.4) 
412 (19.9) 
417 (20.2) 
 
0.95 
Gestational diabetes  10 (5.7) 44 (2.1) 0.007 
Hypertensive disorders in pregnancy 11 (6.3) 78 (3.8) 0.10 
Serum ferritin, µg/L 
Median (25
th
, 75
th 
percentiles) 
 
26.5 (16.2, 52.3) 
 
25.3 (14.3, 42.1) 
 
0.05 
soluble Transferrin receptor, nmol/L 
Median (25
th
, 75
th 
percentiles) 
 
15.2 (11.9, 19.0) 
 
15.1 (12.1, 18.6) 
 
0.61 
C-reactive protein, mg/L 
Median (25
th
, 75
th 
percentiles) 
 
1.0 (0.4, 1.9) 
 
0.7 (0.3, 1.5) 
 
0.01 
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Table 3 
First trimester serum ferritin and soluble transferrin receptor concentrations in women who had a spontaneous onset of labour or preterm 
premature rupture of the membranes (PPROM) and delivered a preterm versus a term infant.    
 
 
 
Preterm birth 
 (<37 weeks)  
Term birth 
(≥37 weeks)  
Unadjusted 
OR (95% CI) 
Adjusted OR
1
  
(95% CI) 
n (%) n (%) 
Serum ferritin, µg/L 
 Median (25
th
, 75
th 
percentiles) 
 
26.5 (16.2, 52.3) 
 
25.3 (14.3, 42.1) 
 
1.24 (1.02, 1.50) 
 
1.17 (0.96, 1.43) 
soluble transferrin receptor (sTfR), nmol/L 
 Median (25
th
, 75
th 
percentiles) 
 
15.2 (11.9, 19.0) 
 
15.1 (12.1, 18.6) 
 
1.02 (0.99, 1.04) 
 
1.01 (0.99, 1.04) 
     
Elevated iron      
 High serum ferritin levels, µg/L     
 >50
th
 percentile (≥25) 95 (54.3) 1, 043 (50.2) 1.18 (0.87, 1.61) -- 
 >75
th
 percentile (≥43) 58 (33.1) 502 (24.2) 1.56 (1.12, 2.17) 1.49 (1.06, 2.10) 
 >90
th
 percentile (≥68) 30 (17.1) 193 (9.3) 2.02 (1.33, 3.08) 1.92 (1.25, 2.96) 
 Low sTfR levels, nmol/L     
 <50
th
 percentile (≤15) 96 (54.9) 1202 (57.8) 0.89 (0.65, 1.21) -- 
 <25
th
 percentile (≤12) 50 (28.6) 663 (31.9) 0.85 (0.61, 1.20) -- 
 <10
th
 percentile (≤9) 24 (13.7) 221 (10.6) 1.34 (0.85, 2.10) -- 
     
Iron deficiency      
 Serum ferritin <12 µg/L 30 (17.1) 402 (19.3) 0.86 (0.57, 1.30) -- 
 sTfR≥21 nmol/L 29 (16.6) 318 (15.3) 1.10 (0.73, 1.67) -- 
1 
Adjusted for maternal age, parity, gestational diabetes mellitus and C-reactive protein. 
Empty cells indicate that adjusted analyses were not performed due to no association being found in univariate analyses.
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SUPPLEMENTARY TABLE 1 
First trimester serum ferritin and soluble transferrin receptor concentrations in women who had a spontaneous onset of labour or preterm 
premature rupture of the membranes (PPROM) and delivered an early or moderate-to-late preterm infant versus a term infant.    
 
 Early preterm vs. Term Moderate-to-late preterm vs. Term 
 
 
 
Early preterm  
 (<34 weeks)  
N=63 
Term  
(≥37 weeks)  
N=2079 
Unadjusted 
odds ratio  
(95% CI) 
Moderate-to-late 
preterm  
(34-36 weeks)  
N=112 
Term  
(≥37 weeks)  
N=2079 
Unadjusted 
odds ratio  
(95% CI) 
 n (%) n (%)  n (%) n (%)  
Serum ferritin, µg/L 
 Median (25
th
, 75
th 
percentiles) 
 
26.4 (17.2, 47.4) 
 
25.3 (14.3, 42.1) 
 
1.28 (0.93, 1.75) 
 
27.0 (15.4, 52.5) 
 
25.3 (14.3, 42.1) 
 
1.22 (0.96, 1.54) 
soluble transferrin receptor, nmol/L 
 Median (25
th
, 75
th 
percentiles) 
 
15.2 (11.5, 18.8) 
 
15.1 (12.1, 18.6) 
 
0.99 (0.94, 1.04) 
 
15.0 (12.7, 19.2) 
 
15.1 (12.1, 18.6) 
 
1.03 (1.00, 1.06)* 
       
Elevated iron       
 High serum ferritin levels, µg/L       
 >50
th
 percentile (≥25) 34 (54.0) 1043 (50.2) 1.17 (0.70, 1.93) 61 (54.5) 1043 (50.2) 1.19 (0.81, 1.74) 
 >75
th
 percentile (≥43) 20 (31.8) 502 (24.2) 1.46 (0.85, 2.51) 38 (33.9) 502 (24.2) 1.61 (1.08, 2.42)* 
 >90
th
 percentile (≥68) 13 (20.6) 193 (9.3) 2.54 (1.36, 4.76)** 17 (15.2) 193 (9.3) 1.75 (1.02, 299)* 
 Low sTfR levels, nmol/L       
 <50
th
 percentile (≤15) 34 (54.0) 1202 (57.8) 0.85 (0.52, 1.41) 62 (55.4) 1202 (57.8) 0.90 (0.62, 1.33) 
 <25
th
 percentile (≤12) 21 (33.3) 663 (31.9) 1.07 (0.63, 1.82) 29 (25.9) 663 (31.9) 0.75 (0.48, 1.15) 
 <10
th
 percentile (≤9) 9 (14.3) 221 (10.6) 1.40 (0.68, 2.88) 15 (13.4) 221 (10.6) 1.30 (0.74, 2.28) 
       
Iron deficiency       
 Serum ferritin <12 µg/L 9 (14.3) 402 (19.3) 0.70 (0.34, 1.42) 21 (18.8) 402 (19.3) 0.96 (0.59, 1.57) 
 sTfR≥21 nmol/L 9 (14.3) 318 (15.3) 0.92 (0.45, 1.89) 20 (17.9) 318 (15.3) 1.20 (0.73, 1.98) 
* P-value<0.05; **P-value <0.005; ***P-value <0.001 
 15 
The association between serum ferritin concentrations >90
th
 percentile did not reach 
statistical significance in the fully adjusted analyses (OR: 1.62, 95% CI: 0.93, 2.84). 
 
 sTfR concentrations by specific cut-offs were not associated with increased odds of early 
sPTB.  The significant association between sTfR and moderate-to-late sPTB found in the 
univariate analysis (OR: 1.03, 95% CI: 1.00, 1.06) was no longer significant in the fully 
adjusted analysis (OR: 1.02; 95% CI: 0.99, 1.06).
 
 
DISCUSSION 
Preterm birth is a major public health concern.  This study found that early pregnancy serum 
ferritin concentrations are significantly elevated in pregnant women with subsequent 
spontaneous preterm labour or preterm premature rupture of membranes (PPROM).  We also 
found that women with sPTB had significantly higher first trimester CRP concentrations and 
that there was no association between sTfR concentrations (a biomarker of iron supplied to 
tissues) and sPTB. These results suggest that serum ferritin levels are elevated as part of acute 
phase reaction and that the inflammatory process associated with sPTB is apparent from the 
first trimester of pregnancy. 
 
Interestingly, this study found that greater maternal body weight and GDM were both 
independently associated with elevated ferritin levels and sPTB and included as confounders 
in the adjusted analyses. Both overweight and GDM are inflammatory conditions. While 
there is some evidence that maternal overweight and obesity during pregnancy is associated 
with increased risks of preterm birth,
(27)
 the association between GDM and sPTB is 
inconsistent and controversial.
(28)
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Results from previous studies examining the association between elevated ferritin and 
preterm birth have been inconsistent.
(1; 10; 11; 12; 13; 14; 15)
  Only one other study measured serum 
ferritin levels in the first trimester in a small sample of 30 cases and 90 controls and found no 
significant difference in the proportion of women with ferritin levels > 75th percentile in the 
early preterm vs. term delivery groups (36.7% vs. 25.6%, P = 0.251).
(29)
   Thresholds for 
elevated serum ferritin have varied as either >50
th
, 75
th
 or 90
th
 percentiles.
(1; 10; 11; 12; 13; 14; 15)
  
In order to compare our study to previous findings, we examined all three of these thresholds. 
We found that serum ferritin levels >75
th
 percentile ( ≥43 µg/L) were associated with 
increased odds of sPTB (<37 weeks) and the sub-category of moderate-to-late sPTB (34-36 
weeks). However, only the higher threshold (>90
th
 percentile) for serum ferritin levels (≥68 
µg/L) was significantly associated with early sPTB in the current study. This is in agreement 
with a few studies which have found levels above 30 µg/L are associated with preterm 
birth.
(11; 14)
  Inconsistent findings across studies may be related to differences in study 
populations and the severity of sPTB, reduced numbers of women in certain categories of the 
exposure and/or outcome and the types of confounders included in adjusted analyses.  
Previous studies have mostly been cross-sectional and limited to serum ferritin measurements 
later in pregnancy or at the time of birth.
(10; 11; 13; 14; 15)
 
 
The usefulness of serum ferritin as a marker for sPTB is uncertain.  Significant associations 
between elevated ferritin and sPTB were not found across all the thresholds or subtypes for 
sPTB (i.e. early versus moderate-to-late).  Before routine screening of serum ferritin for the 
prediction of sPTB can be recommended, further research is needed to establish normative 
values, to understand the variability in ferritin as an early pregnancy biomarker and to 
determine its accuracy, reliability, interpretability, and feasibility.  While the current study 
found a increased odds of sPTB  in association with elevated ferritin and this does not 
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demonstrate that ferritin will function well as a diagnostic test unless ferritin is shown to be a 
manifestation of sPTB.
(30)
 
 
It has been proposed that high ferritin concentrations may be a marker of clinical and 
subclinical vaginal infection which, in turn, may be triggers in the preterm delivery 
pathway.
(10; 13)
  There is evidence of an association between vaginal infections and preterm 
delivery from longitudinal studies
(31; 32)
 and a single randomised controlled trial which found 
second trimester antenatal screening and treatment for asymptomatic vaginal infections 
reduced the rate of preterm births by 50%.
(33)
   The association between maternal iron status 
and vaginal infections in early pregnancy has not been well studied.  Studies have observed 
an increase in various bacterial and non-bacterial infectious diseases in genetic iron overload 
diseases, such as hemochromatosis, where iron levels in serum are increased.
(34)
  Given that a 
notable adaptations of bacterial growth is enhanced virulence secondary to acquiring a supply 
of iron from the host,
(34)
 future studies are needed that examine the relationship between 
maternal iron status and early pregnancy infections.   
 
Strengths of this study include a longitudinal design, one of the largest sample sizes to date 
with measurement of serum ferritin in the first trimester of pregnancy as well as other iron 
and inflammatory biomarkers, adjustment for confounders, and a sensitivity analysis using a 
range of cut-offs for elevated serum ferritin.  Limitations include the lack of data on anaemia, 
other medical conditions which impact iron status, such as haemochromatosis, early 
pregnancy infections and placental iron biomarkers such as serum placental isoferritin. 
 
In summary, results from this study provide further support of an association between 
elevated ferritin concentrations in early pregnancy and risk of sPTB. importantly, this 
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suggests that an inflammatory process which is detectable in early pregnancy may be a 
plausible biological mechanism for this association. Further research investigating the 
pathophysiological processes between elevated ferritin and sPTB, which consider the links 
between inflammation, obesity, GDM and vaginal infections are warranted. 
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